- Home
- BFRG vs CLGN Comparison
BFRG vs CLGN Comparison
Compare BFRG & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRG
- CLGN
- Stock Information
- Founded
- BFRG 2017
- CLGN 2004
- Country
- BFRG United States
- CLGN Israel
- Employees
- BFRG N/A
- CLGN N/A
- Industry
- BFRG Retail: Computer Software & Peripheral Equipment
- CLGN Industrial Specialties
- Sector
- BFRG Technology
- CLGN Health Care
- Exchange
- BFRG Nasdaq
- CLGN Nasdaq
- Market Cap
- BFRG 16.4M
- CLGN 19.1M
- IPO Year
- BFRG 2023
- CLGN N/A
- Fundamental
- Price
- BFRG $1.28
- CLGN $2.63
- Analyst Decision
- BFRG
- CLGN Strong Buy
- Analyst Count
- BFRG 0
- CLGN 2
- Target Price
- BFRG N/A
- CLGN $11.50
- AVG Volume (30 Days)
- BFRG 167.0K
- CLGN 45.8K
- Earning Date
- BFRG 08-13-2025
- CLGN 08-20-2025
- Dividend Yield
- BFRG N/A
- CLGN N/A
- EPS Growth
- BFRG N/A
- CLGN N/A
- EPS
- BFRG N/A
- CLGN N/A
- Revenue
- BFRG $33,257.00
- CLGN $2,472,000.00
- Revenue This Year
- BFRG N/A
- CLGN $1,999.42
- Revenue Next Year
- BFRG N/A
- CLGN $69.81
- P/E Ratio
- BFRG N/A
- CLGN N/A
- Revenue Growth
- BFRG N/A
- CLGN N/A
- 52 Week Low
- BFRG $1.23
- CLGN $1.31
- 52 Week High
- BFRG $4.84
- CLGN $5.45
- Technical
- Relative Strength Index (RSI)
- BFRG 37.17
- CLGN 60.49
- Support Level
- BFRG $1.24
- CLGN $2.59
- Resistance Level
- BFRG $1.34
- CLGN $3.23
- Average True Range (ATR)
- BFRG 0.07
- CLGN 0.29
- MACD
- BFRG -0.00
- CLGN 0.03
- Stochastic Oscillator
- BFRG 16.39
- CLGN 55.86
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.